Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DM8ABD6)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
CHEMBL317757; DIFLUOROBENZTROPINE; 4,4'-DifluoroBZT; AC1MZYZJ; Biomol-NT_000053; Lopac0_000439; SCHEMBL6478352; BPBio1_001309; SCHEMBL12648564; BDBM86701; CHEBI:110199; NCGC00024872-02; LS-190982; BRD-A85216385-003-01-6; 3-[bis(4-fluorophenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane; 3-[Bis-(4-fluoro-phenyl)-methoxy]-8-methyl-8-azonia-bicyclo[3.2.1]octane; 3-(bis(4-fluorophenyl)methoxy)-8-methyl-8-aza-bicyclo[3.2.1]octane
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||
|
||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
|
||||||||||||||||||||||||
